DE3029111C2 - - Google Patents

Info

Publication number
DE3029111C2
DE3029111C2 DE3029111A DE3029111A DE3029111C2 DE 3029111 C2 DE3029111 C2 DE 3029111C2 DE 3029111 A DE3029111 A DE 3029111A DE 3029111 A DE3029111 A DE 3029111A DE 3029111 C2 DE3029111 C2 DE 3029111C2
Authority
DE
Germany
Prior art keywords
glycoproteins
precipitate
klebsiella pneumoniae
molecular weight
glycoprotein
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE3029111A
Other languages
German (de)
English (en)
Other versions
DE3029111A1 (de
Inventor
Bernard Villeneuve D'ascq Fr Fournet
Rene Saint-Ouen L'aumone Fr Zalisz
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sanofi Aventis France
Original Assignee
Roussel Uclaf SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Roussel Uclaf SA filed Critical Roussel Uclaf SA
Publication of DE3029111A1 publication Critical patent/DE3029111A1/de
Application granted granted Critical
Publication of DE3029111C2 publication Critical patent/DE3029111C2/de
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C12P21/005—Glycopeptides, glycoproteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/24—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia
    • C07K14/26—Klebsiella (G)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/22—Klebsiella

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biochemistry (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biotechnology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Microbiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Virology (AREA)
  • Biomedical Technology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
DE19803029111 1979-07-31 1980-07-31 Neue glykoproteine von klebsiella pneumoniae, verfahren zu deren herstellung, deren verwendung als arzneimittel und die diese enthaltenden zusammensetzungen Granted DE3029111A1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR7919652A FR2462477A1 (fr) 1979-07-31 1979-07-31 Nouvelles glycoproteines de klebsiella pneumoniae, procede d'obtention, application a titre de medicaments et compositions les renfermant

Publications (2)

Publication Number Publication Date
DE3029111A1 DE3029111A1 (de) 1981-02-19
DE3029111C2 true DE3029111C2 (en, 2012) 1990-03-22

Family

ID=9228477

Family Applications (1)

Application Number Title Priority Date Filing Date
DE19803029111 Granted DE3029111A1 (de) 1979-07-31 1980-07-31 Neue glykoproteine von klebsiella pneumoniae, verfahren zu deren herstellung, deren verwendung als arzneimittel und die diese enthaltenden zusammensetzungen

Country Status (6)

Country Link
JP (1) JPS5622793A (en, 2012)
CH (1) CH645130A5 (en, 2012)
DE (1) DE3029111A1 (en, 2012)
FR (1) FR2462477A1 (en, 2012)
GB (1) GB2060645B (en, 2012)
NL (1) NL8004406A (en, 2012)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2490495A1 (fr) * 1980-09-19 1982-03-26 Roussel Uclaf Nouvelles glycoproteines hydrosolubles immunostimulantes extraites de klebsiella pneumoniae, leur procede d'obtention, leur application a titre de medicaments et les compositions les renfermant
FR2540136A1 (fr) * 1983-01-28 1984-08-03 Roussel Uclaf Nouveau procede de preparation d'acylglycoproteines immunostimulantes extraites de klebsiella pneumoniae, compositions pharmaceutiques et procede de lutte contre les maladies allergiques
FR2490496A1 (fr) * 1980-09-19 1982-03-26 Roussel Uclaf Nouvelles glycoproteines immunostimulantes extraites de klebsiella pneumoniae, leur procede d'obtention, leur application a titre de medicaments et les compositions les renfermant
FR2574429B1 (fr) * 1984-12-06 1987-12-11 Roussel Uclaf Acylglycannes extraits de klebsiella, leur procede d'obtention, leur application a titre de medicaments et les compositions les renfermant
JP2522945B2 (ja) * 1987-06-18 1996-08-07 呉羽化学工業株式会社 抗レトロウィルス剤
FR2653014B1 (fr) * 1989-10-17 1994-09-16 Roussel Uclaf Utilisation de glycoproteines extraites de bacteries gram (-) pour la fabrication de compositions cosmetiques ou dermatologiques et compositions les renfermant.
CH699786A2 (fr) * 2008-10-31 2010-05-14 Marie-Christine Dr Etienne Médicament déstiné à traiter des infections.

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL174267B (nl) * 1969-05-20 Roussel Uclaf Verbetering van de werkwijze voor de bereiding van een somatisch antigeen volgens het nederlandse octrooischrift 169754 en werkwijze ter bereiding van een farmaceutisch preparaat.
BE795417A (fr) * 1972-02-15 1973-08-14 Roussel Uclaf Nouveaux composes d'origine-bacterienne et procede d'obtention
FR2396020A1 (fr) * 1977-07-01 1979-01-26 Cassenne Lab Sa Nouveaux glycopeptides acetyles hydrosolubles extraits de corps microbiens lyses d'hafnia, d'aerobacter cloacae et de klebsiella pneumoniae, procede de preparation et application a titre de medicaments de ces produits

Also Published As

Publication number Publication date
JPS6363560B2 (en, 2012) 1988-12-07
DE3029111A1 (de) 1981-02-19
CH645130A5 (fr) 1984-09-14
FR2462477A1 (fr) 1981-02-13
FR2462477B1 (en, 2012) 1983-12-30
NL8004406A (nl) 1981-02-03
GB2060645B (en) 1983-03-23
JPS5622793A (en) 1981-03-03
GB2060645A (en) 1981-05-07

Similar Documents

Publication Publication Date Title
DE3125260C2 (de) Wasserhaltiges, viscoelastisches Gemisch enthaltend Hyaluronat und kosmetische Mittel enthaltend diese Gemische
DE2725204C2 (de) Verfahren zum Herstellen eines die unspezifische Immunität stimulierenden löslichen Mikroorganismenextrakts und diesem enthaltendes Arzneimittel
DE2655844C3 (de) Verfahren zur Herstellung antitumorwirksamer Substanzen
DE2331144A1 (de) Wasserloesliche extrakte von mycobacterien
DE3407823A1 (de) Lipopolysaccharid und verfahren zu seiner herstellung
DE2519938A1 (de) Extrakte von corynebakterien, verfahren zu ihrer herstellung und ihre verwendung in arzneimittelzubereitungen
DE3448148C2 (en, 2012)
DE3029111C2 (en, 2012)
DE69724923T2 (de) Niedermolekulare Fukane mit blutgerinnungshemmender, antithrombinischer und antithrombotischer Wirkung
DE69634530T2 (de) Antivirales mittel und verfahren zu dessen herstellung
DE2926406A1 (de) Praeparat zur behandlung maligner neoplasien und verfahren zu seiner herstellung
DE2947646C2 (de) Substanz mit Interferon induzierender Aktivität, Verfahren zu ihrer Herstellung und ihre Verwendung
DE3152621C2 (en, 2012)
DE3418820A1 (de) Arzneimittel fuer verdauungsgeschwuer
DE3850262T2 (de) Verfahren zur herstellung einer physiologisch aktiven substanz aus samenschalen von föhren und ein gegen infektionen aktives mittel, hauptsächlich auf der basis von diesem extrakt.
DE3427477C2 (en, 2012)
DE3019895C2 (en, 2012)
DE3914354C1 (en, 2012)
DE2803001A1 (de) Neue aus hafnia isolierte glykoproteine, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammensetzungen
DE2307051B2 (de) Verfahren zum Reinigen von langsamen a - und ß -Glykoproteinen aus Mikrobenkörpern und diese enthaltende pharmazeutische Zusammensetzungen
DE3543267A1 (de) Acylglykan-extrakte von klebsiella, deren gewinnungsverfahren, deren verwendung als arzneimittel und die sie enthaltenden zusammensetzungen
DE2829975A1 (de) Antitumor wirksame substanz, deren herstellung und verwendung
DE4104728A1 (de) Medikament zur behandlung der dermatitis
DE2659431A1 (de) Verfahren zur gewinnung einer atoxischen, biologisch aktiven fraktion, die dabei erhaltene fraktion und sie enthaltende arzneimittel
DE3004018C2 (en, 2012)

Legal Events

Date Code Title Description
8110 Request for examination paragraph 44
8128 New person/name/address of the agent

Representative=s name: ASSMANN, E., DIPL.-CHEM. DR.RER.NAT. KLINGSEISEN,

D2 Grant after examination
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee